# The Alpha-1 Foundation's and University of Florida's Alpha-1 Coded Testing (ACT) Study

> **NCT00500123** · — · RECRUITING · sponsor: **University of Florida** · enrollment: 50000 (estimated)

## Conditions studied

- Alpha-1 Antitrypsin Deficiency

## Interventions

- **PROCEDURE:** Alpha-1 Antitrypsin Genotype

## Key facts

- **NCT ID:** NCT00500123
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2001-01
- **Primary completion:** 2050-01
- **Final completion:** 2050-01
- **Target enrollment:** 50000 (ESTIMATED)
- **Last updated:** 2025-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00500123

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00500123, "The Alpha-1 Foundation's and University of Florida's Alpha-1 Coded Testing (ACT) Study". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00500123. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*